Bronchix Pulmo - A revolutionary pulmonary product
Respiratory diseases can be considered as the second most common cause of loss of performance in sport horses and racehorses after musculoskeletal problems.
The overall prevalence of respiratory diseases is most probably underestimated due to the fact that some chronic forms of diseases may develop sub clinically, although they still impede performance.
Lower Airway Issues
Whatever the type of sport, most lower airway diseases cause a significant decrease in athletic parameters and delayed cardio-respiratory recovery. The main lower respiratory diseases involved in poor performance reported are inflammatory airway disease (IAD), recurrent airway obstruction (RAO), exercise induced pulmonary haemorrhage (EIPH) and viral or bacterial infections.
Several factors inevitably promote the occurrence of inflammatory diseases, such as age (higher prevalence in older individuals), pollution and other environmental conditions.
Horses are often housed indoors in buildings were ventilation within the boxes is limited, indoor storage of hay and straw can be encountered and doors and windows are often closed during the cold months.
This type of management promotes chronic respiratory inflammation.
Intensive training, repeated transportation and mixing with other horses in competition may promote the development of infectious disease.
Moreover, competition itself is also a key factor in the prevalence of lower airway diseases in horses. Competition may trigger metabolic and hormonal alterations, which disturb immunity.
Depression of the immune system and the occurrence of repeated inflammatory and oxidative processes during training and competitions seem to create favorable conditions to the outbreak of infectious respiratory diseases.
These respiratory problems are often subclinical but have an impact on performance and may impede the pursuit of their physical preparation as well as post-race short and long-term recovery.
What is Exercise Induced Pulmonary Haemorrhage
Exercise-induced pulmonary haemorrhage (EIPH) is a unique respiratory condition that results in the shedding of blood in the lungs and airways after a sufficient strenuous exercise.
Pulmonary haemorrhages have been shown to be associated with pulmonary inflammation and fibrosis, gas exchange disturbances during exercise and subsequent poor performance. EIPH can also affect negatively the duration of the career of sport horses and race horses.
- Post Effort bleeding from the nostrils
- Trachea wash sampling
Less than 5% of horses that bleed show evidence of this through outward bleeding.
Prevalence is as high as 95%
Eventing, Polo, Showjumping
In all disciplines including intense or fast bouts of exercises, horses have been diagnosed with EIPH.
Recent studies show this may be as high as 50% of jumping horses in 4 and 5* competitions.
The only effective pharmaceutical treatment for the management of horses with EIPH is furosemide (Lasix). It is, however banned by pretty much all authorities including the FEI and all racing in Europe, Asia and Australia.
This study demonstrated that the use of daily Cavalor Bronchix Pulmo oral supplementation during a 25 day period signifi cantly reduces the incidence and severity of EIPH in Thoroughbred racehorses during a period of intensive training. Non of the horses studied bled at T2.
The results also show that Cavalor Bronchix Pulmo has a mild anti-infl ammatory eff ect and reduces signs of infl ammation in the lower airways.
Cavalor Bronchix Pulmo is an oral supplement that can be given to horses as a preventative measure to avoid the occurrence of EIPH.